ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Jewish General Hospital at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Jewish General Hospital takes part in 4 sessions at ESMO 2026 in Madrid. Its work spans cancer treatment and access to care. It examines breast tumour responses during treatment with trastuzumab deruxtecan and other medicines, and access to early cancer drugs for women in Quebec.
| Organization | ESMO 2026 Attendance |
|---|---|
Jewish General Hospital Montreal, Canada | |
Teaching hospital of McGill University in Montreal, Canada, with a cancer centre. | Poster Fri Oct 23 13:00–15:00 Plasma proteomics reveals a Th17/myeloid signature in ICI-induced colitis: A MIRAE pilot study Biomarkers & precision oncology Abstract Fri Oct 23 17:09–17:14 Abstract Sat Oct 24 17:42–17:54 LBA4 - Darolutamide with androgen deprivation therapy (ADT) and definitive or salvage locoregional radiation therapy (RT) for localised, very high-risk prostate cancer: Interim analysis of an international, placebo-controlled, randomised phase 3 trial (DASL-HiCaP; ANZUP1801) Lung & thoracic cancersMelanoma & skin cancersGenitourinary cancers Poster Sun Oct 25 12:00–12:45 Assessing equity in early oncology drug access for women’s cancers across Quebec’s health system Gynaecological cancersBreast cancer |
Find decision makers at Jewish General Hospital
Tell us what you sell and we’ll find the people at Jewish General Hospital most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction